Paper679171
Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners.
Loike JD and 4 others. Cancer Res, 1978. Cited by 131 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners. Papers, record 679171. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/679171
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Microtubules | Major topic |
| Podophyllotoxin | Major topic |
| Animals | |
| Etoposide | |
| In Vitro Techniques | |
| Magnetic Resonance Spectroscopy | |
| Stereoisomerism | |
| Structure-Activity Relationship | |
| Teniposide | |
| Tubulin |
Source PubMed
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 131 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,155,768 | HPV16 E2 protein possesses intrinsic helicase activity and sterically hinders E1 function through direct interaction. | J Biol Chem | 2026 | https://conductscience.org/library/papers/42155768 | PubMed |
| 38,674,496 | Anthriscus sylvestris-Noxious Weed or Sustainable Source of Bioactive Lignans? | Plants (Basel) | 2024 | https://conductscience.org/library/papers/38674496 | PubMed |
| 36,039,387 | Deoxypodophyllotoxin Induces ROS-Mediated Apoptosis by Modulating the PI3K/AKT and p38 MAPK-Dependent Signaling in Oral Squamous Cell Carcinoma. | J Microbiol Biotechnol | 2022 | https://conductscience.org/library/papers/36039387 | PubMed |
| 34,008,964 | Topoisomerase II Poisons: Converting Essential Enzymes into Molecular Scissors. | Biochemistry | 2021 | https://conductscience.org/library/papers/34008964 | PubMed |
| 33,574,882 | Design and Synthesis of 4-O-Podophyllotoxin Sulfamate Derivatives as Potential Cytotoxic Agents. | Evid Based Complement Alternat Med | 2021 | https://conductscience.org/library/papers/33574882 | PubMed |
| 31,027,384 | Perspectives on the Use of a Medium-Dose Etoposide, Cyclophosphamide, and Total Body Irradiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation: The Japanese Experience from 1993 to Present. | J Clin Med | 2019 | https://conductscience.org/library/papers/31027384 | PubMed |
| 26,458,924 | Total Synthesis of Lignan Lactone (-)-Hinokinin. | Nat Prod Bioprospect | 2015 | https://conductscience.org/library/papers/26458924 | PubMed |
| 26,287,153 | Ethnomedicinal, Phytochemical and Pharmacological Profile of Anthriscus sylvestris as an Alternative Source for Anticancer Lignans. | Molecules | 2015 | https://conductscience.org/library/papers/26287153 | PubMed |
| 26,021,470 | Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells. | Med Oncol | 2015 | https://conductscience.org/library/papers/26021470 | PubMed |
| 24,205,161 | An open source based high content screening method for cell biology laboratories investigating cell spreading and adhesion. | PLoS One | 2013 | https://conductscience.org/library/papers/24205161 | PubMed |
| 20,030,375 | Eribulin binds at microtubule ends to a single site on tubulin to suppress dynamic instability. | Biochemistry | 2010 | https://conductscience.org/library/papers/20030375 | PubMed |
| 19,052,697 | Molecular modelling evaluation of the cytotoxic activity of podophyllotoxin analogues. | J Comput Aided Mol Des | 2009 | https://conductscience.org/library/papers/19052697 | PubMed |
| 18,404,326 | An efficient method of propagation of Podophyllum hexandrum: an endangered medicinal plant of the Western Himalayas under ex situ conditions. | J Nat Med | 2008 | https://conductscience.org/library/papers/18404326 | PubMed |
| 18,338,104 | Temperature-dependent growth and emergence of functional leaves: an adaptive mechanism in the seedlings of the western Himalayan plant Podophyllum hexandrum. | J Plant Res | 2008 | https://conductscience.org/library/papers/18338104 | PubMed |
| 15,139,794 | Pharmacokinetic optimisation of treatment with oral etoposide. | Clin Pharmacokinet | 2004 | https://conductscience.org/library/papers/15139794 | PubMed |
| 8,070,021 | Teniposide: overview of its therapeutic potential in adult cancers. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/8070021 | PubMed |
| 7,083,465 | Modification of the pendant ring of podophyllotoxin. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/7083465 | PubMed |
| 7,044,591 | VP16-213 and podophyllotoxin. A study on the relationship between chemical structure and biological activity. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/7044591 | PubMed |
| 7,031,350 | [Etoposide VP 16--213)--a podophyllotoxinderivative with high antitumor activity (author's transl)]. | Klin Wochenschr | 1981 | https://conductscience.org/library/papers/7031350 | PubMed |
| 6,488,441 | Pharmacokinetic study of VM26 given as a prolonged IV infusion to ovarian cancer patients. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6488441 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/679171
GET https://conductscience.org/api/papers/v1/679171/cited_by?page=2